30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jean-Jacques Bienaime

Track

Insider profile

Currently holds positions in Biomarin Pharmaceutical Inc, InterMune Inc and Immunic Inc

Performance

Overall performance
2.9
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 41% 68% 82%
Transactions
31 45% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -16%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Director Biomarin Pharmaceutical Inc May 1, 2005 -
Independent Director InterMune Inc March 26, 2012 -
Independent Director Immunic Inc Sept. 20, 2013 -
Independent Director Portola Pharmaceuticals Inc Sept. 1, 2010 - June 30, 2014
Jean-Jacques Bienaime's trades of Keros Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15
PP Planned purchase
8,898 -25.1%
197.90
US$2,574,366 		8,898 -25.1% 197.90 US$2,574,366
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
49,465 +8.7%
89.48
US$2,641,661 		49,465 +8.7% 89.48 US$2,641,661
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
81,448 -3.9%
422.88
US$4,625,965 		81,448 -3.9% 422.88 US$4,625,965
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
3,500 +9.0%
19.46
US$68,110 		3,500 +9.0% 19.46 US$68,110
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
3,500 +9.0%
19.46
US$68,110 		3,500 +9.0% 19.46 US$68,110
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
6,000 +18.2%
19.48
US$116,880 		6,000 +18.2% 19.48 US$116,880
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
B Purchase
6,000 +18.2%
19.48
US$116,880 		6,000 +18.2% 19.48 US$116,880
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
10,000 -23.3%
19.41
US$194,100 		10,000 -23.3% 19.41 US$194,100
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
10,000 -23.3%
19.41
US$194,100 		10,000 -23.3% 19.41 US$194,100
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
500 -1.2%
19.44
US$9,720 		500 -1.2% 19.44 US$9,720
2026-06-09 2026-06-05
US Immunome Inc (IMNM)
S Sale
500 -1.2%
19.44
US$9,720 		500 -1.2% 19.44 US$9,720
2026-06-01 2026-05-29
B Purchase
100 +12.5%
223.50
US$22,350 		100 +12.5% 223.50 US$22,350
2026-06-01 2026-05-29
B Purchase
200 +33.3%
222.30
US$44,460 		200 +33.3% 222.30 US$44,460
2026-06-01 2026-05-29
B Purchase
200 +50.0%
223.76
US$44,752 		200 +50.0% 223.76 US$44,752
2026-05-27 2026-05-26
B Purchase
200 +100.0%
239.37
US$47,874 		200 +100.0% 239.37 US$47,874
2026-05-27 2026-05-26
B Purchase
200 +inf%
236.24
US$47,247 		200 +inf% 236.24 US$47,247
2026-05-19 2026-05-15
PP Planned purchase
1,000 +11.8%
10.58
US$10,580 		1,000 +11.8% 10.58 US$10,580
2026-05-19 2026-05-15
US Immunome Inc (IMNM)
B Purchase
5,000 +13.0%
20.70
US$103,500 		5,000 +13.0% 20.70 US$103,500
2026-04-17 2026-04-15
PP Planned purchase
1,000 +13.4%
11.70
US$11,700 		1,000 +13.4% 11.70 US$11,700
2026-03-12 2026-03-11
US Immunome Inc (IMNM)
B Purchase
1,000 +2.7%
21.55
US$21,550 		1,000 +2.7% 21.55 US$21,550
2026-03-12 2026-03-10
US Immunome Inc (IMNM)
B Purchase
1,000 +2.7%
22.12
US$22,120 		1,000 +2.7% 22.12 US$22,120
2026-03-11 2026-03-09
PP Planned purchase
2,000 +36.7%
11.21
US$22,420 		2,000 +36.7% 11.21 US$22,420
2025-06-03 2025-06-03
US Immunome Inc (IMNM)
B Purchase
5,000 +15.9%
9.38
US$46,900 		5,000 +15.9% 9.38 US$46,900
2025-03-26 2025-03-25
US Immunome Inc (IMNM)
B Purchase
7,800 +33.0%
7.78
US$60,684 		7,800 +33.0% 7.78 US$60,684
2025-03-25 2025-03-24
US Immunome Inc (IMNM)
B Purchase
7,000 +42.1%
8.21
US$57,470 		7,000 +42.1% 8.21 US$57,470
2024-08-19 2024-08-16
US Immunome Inc (IMNM)
B Purchase
7,000 +72.8%
13.94
US$97,608 		7,000 +72.8% 13.94 US$97,608
2024-05-31 2024-05-31
PrS Proposed sale
31,000
74.54
US$2,310,740 		31,000 74.54 US$2,310,740
2024-05-30 2024-05-30
PrS Proposed sale
20,000
75.19
US$1,503,800 		20,000 75.19 US$1,503,800
2024-05-22 2024-05-21
US Immunome Inc (IMNM)
B Purchase
2,000 +26.3%
13.57
US$27,140 		2,000 +26.3% 13.57 US$27,140
2024-05-13 2024-05-10
PlS Planned sale
20,000 -4.0%
81.14
US$1,622,800 		20,000 -4.0% 81.14 US$1,622,800
2024-05-13 2024-05-10
PlS Planned sale
20,000 -4.0%
81.14
US$1,622,800 		20,000 -4.0% 81.14 US$1,622,800
2024-05-10 2024-05-10
PrS Proposed sale
20,000
81.14
US$1,622,800 		20,000 81.14 US$1,622,800
2024-05-13 2024-05-09
PlS Planned sale
20,000 -4.0%
81.62
US$1,632,400 		20,000 -4.0% 81.62 US$1,632,400
2024-05-13 2024-05-09
PlS Planned sale
20,000 -4.0%
81.62
US$1,632,400 		20,000 -4.0% 81.62 US$1,632,400
2024-05-09 2024-05-09
PrS Proposed sale
20,000
81.62
US$1,632,400 		20,000 81.62 US$1,632,400
2024-04-15 2024-04-12
PlS Planned sale
20,000 -4.0%
91.26
US$1,825,200 		20,000 -4.0% 91.26 US$1,825,200
2024-04-12 2024-04-12
PrS Proposed sale
20,000
91.26
US$1,825,200 		20,000 91.26 US$1,825,200
2024-04-15 2024-04-11
PlS Planned sale
20,000 -4.0%
90.99
US$1,819,800 		20,000 -4.0% 90.99 US$1,819,800
2024-04-11 2024-04-11
PrS Proposed sale
20,000
90.99
US$1,819,800 		20,000 90.99 US$1,819,800
2024-03-07 2024-03-06
S Sale
1,000 -0.2%
86.71
US$86,713 		1,000 -0.2% 86.71 US$86,713
2024-03-06 2024-03-06
PrS Proposed sale
1,000
86.71
US$86,713 		1,000 86.71 US$86,713
2024-03-07 2024-03-05
S Sale
1,000 -0.2%
85.51
US$85,510 		1,000 -0.2% 85.51 US$85,510
2024-03-05 2024-03-05
PrS Proposed sale
1,000
85.51
US$85,510 		1,000 85.51 US$85,510
2024-02-29 2024-02-27
S Sale
1,000 -0.2%
90.35
US$90,350 		1,000 -0.2% 90.35 US$90,350
2024-02-27 2024-02-27
PrS Proposed sale
1,000
90.35
US$90,350 		1,000 90.35 US$90,350